Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Kamada Ltd (NQ: KMDA )

4.580 -0.090 (-1.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,107
Open 4.600
Bid (Size) 4.510 (7)
Ask (Size) 4.580 (3)
Prev. Close 4.670
Today's Range 4.460 - 4.600
52wk Range 4.460 - 6.960
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Recap: Kamada Q1 Earnings
Kamada (NASDAQ:KMDA) reported its Q1 earnings results on Tuesday, May 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For May 17, 2022
Companies Reporting Before The Bell • On Holding (NYSE:ONON) is likely to report earnings for its first quarter. 
Via Benzinga

Performance

YTD
-30.61%
-30.61%
1 Month
-15.50%
-15.50%
3 Month
-19.93%
-19.93%
6 Month
-29.32%
-29.32%
1 Year
-23.54%
-23.54%

More News

Read More
Earnings Preview For Kamada
Via Benzinga
Kamada: Q4 Earnings Insights
Via Benzinga
Earnings Preview: Kamada
Via Benzinga
Kamada: Q3 Earnings Insights
Via Benzinga
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Via Benzinga
Exposures Product Safety
Earnings Scheduled For March 15, 2022
Via Benzinga
Kamada Stock Jumps After Acquisition Of Four Plasma-Derived Products
Via Benzinga
Earnings Scheduled For November 22, 2021
Via Benzinga
Kamada's Earnings Outlook
Via Benzinga
Kamada's Earnings: A Preview
Via Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Via Benzinga
Exposures COVID-19
Kamada's Earnings Outlook
Via Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Via Benzinga
Exposures Product Safety
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Via Benzinga
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Via Benzinga
Exposures Product Safety
Earnings Scheduled For May 12, 2021
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.